drugset / Trial / NCT00102141
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
RandomizedFactorialDouble-blindTreatment
Summary
The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8 weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the relief of vasomotor symptoms and who have hypertension.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 17ß-estradiol | Unknown | 1 mg | Oral |
| Subject | drospirenone | Unknown | 1 mg | Oral |
| Subject | drospirenone | Unknown | 2 mg | Oral |
| Subject | drospirenone | Unknown | 3 mg | Oral |